Rho Capital Partners Inc Ngm Biopharmaceuticals Inc Put Options Transaction History

Rho Capital Partners Inc

  • $20.2 Million
  • Q3 2023

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Rho Capital Partners Inc Portfolio

Follow Rho Capital Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rho Capital Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Rho Capital Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email